{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:17:37Z","timestamp":1784557057712,"version":"3.55.0"},"reference-count":15,"publisher":"Bioscientifica","issue":"12","license":[{"start":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T00:00:00Z","timestamp":1698624000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,30]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The European Registries for Rare Endocrine Conditions (EuRRECa, eurreb.eu) includes an e-reporting registry (e-REC) used to perform surveillance of conditions within the European Reference Network (ERN) for rare endocrine conditions (Endo-ERN). The aim of this study was to report the experience of e-REC over the 3.5 years since its launch in 2018.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Electronic reporting capturing new encounters of Endo-ERN conditions was performed monthly through a bespoke platform by clinicians registered to participate in e-REC from July 2018 to December 2021.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The number of centres reporting on e-REC increased to a total of 61 centres from 22 countries. A median of 29 (range 11, 45) paediatric and 32 (14, 51) adult centres had reported cases monthly. A total of 9715 and 4243 new cases were reported in adults (age \u226518 years) and children, respectively. In children, sex development conditions comprised 40% of all reported conditions and transgender cases were most frequently reported, comprising 58% of sex development conditions. The median number of sex development cases reported per centre per month was 0.6 (0, 38). Amongst adults, pituitary conditions comprised 44% of reported conditions and pituitary adenomas (69% of cases) were most commonly reported. The median number of pituitary cases reported per centre per month was 4 (0.4, 33).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>e-REC has gained increasing acceptability over the last 3.5 years for capturing brief information on new encounters of rare conditions and shows wide variations in the rate of presentation of these conditions to centres within a reference network.<\/jats:p>\n                    <jats:p>\n                      <jats:bold>Significance statement<\/jats:bold>\n                    <\/jats:p>\n                    <jats:p>Endocrinology includes a very wide range of rare conditions and their occurrence is often difficult to measure. By using an electronic platform that allowed monthly reporting of new clinical encounters of several rare endocrine conditions within a defined network that consisted of several reference centres in Europe, the EuRRECa project shows that a programme of e-surveillance is feasible and acceptable. The data that have been collected by the e-reporting of rare endocrine conditions (e-REC) can allow the continuous monitoring of rare conditions and may be used for clinical benchmarking, designing new studies or recruiting to clinical trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/ec-23-0434","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T12:17:45Z","timestamp":1698668265000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":4,"title":["Electronic reporting of rare endocrine conditions within a clinical network: results from the EuRRECa project"],"prefix":"10.1530","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2178-269X","authenticated-orcid":true,"given":"S R","family":"Ali","sequence":"first","affiliation":[{"name":"Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK"},{"name":"Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bryce","sequence":"additional","affiliation":[{"name":"Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Priego-Zurita","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cherenko","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Smythe","sequence":"additional","affiliation":[{"name":"Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T M","family":"de Rooij","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9552-4899","authenticated-orcid":true,"given":"M","family":"Cools","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Paediatrics, Ghent University, Belgium"},{"name":"Department of Paediatric Endocrinology, Ghent University Hospital, Ghent, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Danne","sequence":"additional","affiliation":[{"name":"Diabetes Center AUF DER BULT, Hannover, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Katugampola","sequence":"additional","affiliation":[{"name":"UCL GOS Institute of Child Health, London"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O M","family":"Dekkers","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"},{"name":"Department of Medicine & Clinical Epidemiology, Leiden University Medical Centre, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Hiort","sequence":"additional","affiliation":[{"name":"Division of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, University of L\u00fcbeck, L\u00fcbeck, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Linglart","sequence":"additional","affiliation":[{"name":"AP-HP, Universit\u00e9 Paris Saclay, INSERM, Bic\u00eatre Paris Saclay Hospital, le Kremlin Bic\u00eatre, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Netchine","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Inserm, Centre de recherche Sainte Antoine, APHP, H\u00f4pital des Enfants Armand Trousseau, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nordenstrom","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Attila","sequence":"additional","affiliation":[{"name":"Clinical Genetics and Endocrinology Laboratory, Department of Laboratory Medicine, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2068-9581","authenticated-orcid":true,"given":"L","family":"Persani","sequence":"additional","affiliation":[{"name":"Department of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano IRCCS, Milan, Italy"},{"name":"Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-6069","authenticated-orcid":true,"given":"N","family":"Reisch","sequence":"additional","affiliation":[{"name":"Endokrinologie, Medizinische Klinik Innenstadt und Poliklinik IV, Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Smyth","sequence":"additional","affiliation":[{"name":"Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Sumnik","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Motol University Hospital and 2nd Faculty of Medicine, Charles University, Prague, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Taruscio","sequence":"additional","affiliation":[{"name":"National Centre for Rare Diseases, Istituto Superiore di Sanit\u00e0, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W E","family":"Visser","sequence":"additional","affiliation":[{"name":"Erasmus Medical Centre, Department of Internal Medicine, Academic Centre for Thyroid Diseases, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, the Netherlands"},{"name":"Amsterdam Gastroenterology Endocrinology and Metabolism, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N M","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-5549","authenticated-orcid":true,"given":"S F","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Developmental Endocrinology Research Group, School of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow, UK"},{"name":"Office for Rare Conditions, Royal Hospital for Children & Queen Elizabeth University Hospital, Glasgow, UK"},{"name":"Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Frontiers in Endocrinology","first-page":"694325","article-title":"The burden of hormonal disorders: a worldwide overview with a particular look in Italy","volume":"12","author":"Crafa","year":"2021","unstructured":"Crafa ACalogero AECannarella RMongioi LMCondorelli RAGreco EAAversa A & La Vignera S. The burden of hormonal disorders: a worldwide overview with a particular look in Italy. Frontiers in Endocrinology202112694325. (https:\/\/doi.org\/10.3389\/fendo.2021.694325)"},{"key":"bib2","series-title":"Euro Surveillance","first-page":"E060720.4","article-title":"Twenty years of active paediatric surveillance in the the UK and Republic of Ireland","volume":"11","author":"Lynn","year":"2006","unstructured":"Lynn RMPebody R & Knowles R. Twenty years of active paediatric surveillance in the the UK and Republic of Ireland. Euro Surveillance200611E060720.4. (https:\/\/doi.org\/10.2807\/esw.11.29.03005-en)"},{"key":"bib3","series-title":"Paediatrics and Child Health","first-page":"251","article-title":"Rare disease surveillance: an international perspective","volume":"6","author":"Elliott","year":"2001","unstructured":"Elliott EJNicoll ALynn RMarchessault VHirasing R & Ridley G. Rare disease surveillance: an international perspective. Paediatrics and Child Health20016251\u2013260."},{"key":"bib4","series-title":"Journal of Pediatric Endocrinology and Metabolism","first-page":"1053","article-title":"An electronic surveillance system for monitoring the hospital presentation of nutritional vitamin D deficiency in children in Scotland","volume":"26","author":"El-Fakhri","year":"2013","unstructured":"El-Fakhri NWilliams CCox KMcDevitt HGalloway PMcIntosh N & Ahmed SF. An electronic surveillance system for monitoring the hospital presentation of nutritional vitamin D deficiency in children in Scotland. Journal of Pediatric Endocrinology and Metabolism2013261053\u20131058. (https:\/\/doi.org\/10.1515\/jpem-2013-0175)"},{"key":"bib5","series-title":"Sexual Development","first-page":"11","article-title":"A nationwide study of the prevalence and initial management of atypical genitalia in the newborn in Scotland","volume":"16","author":"Rodie","year":"2022","unstructured":"Rodie MEAli SRJayasena AAlenazi NRMcMillan MCox KCassim SMHenderson SMcGowan RAhmed SF, et al.A nationwide study of the prevalence and initial management of atypical genitalia in the newborn in Scotland. Sexual Development20221611\u201318. (https:\/\/doi.org\/10.1159\/000517327)"},{"key":"bib6","series-title":"Journal of Biomedical Informatics","first-page":"103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","unstructured":"Harris PATaylor RMinor BLElliott VFernandez MO'Neal LMcLeod LDelacqua GDelacqua FKirby J, et al.The REDCap consortium: building an international community of software platform partners. Journal of Biomedical Informatics201995103208. (https:\/\/doi.org\/10.1016\/j.jbi.2019.103208)"},{"key":"bib7","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"1853","article-title":"Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review","volume":"94","author":"Golden","year":"2009","unstructured":"Golden SHRobinson KASaldanha IAnton B & Ladenson PW. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. Journal of Clinical Endocrinology and Metabolism2009941853\u20131878. (https:\/\/doi.org\/10.1210\/jc.2008-2291)"},{"key":"bib8","series-title":"Diabetes Care","first-page":"587","article-title":"Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation","volume":"31","author":"Ford","year":"2008","unstructured":"Ford ESLi CZhao GPearson WS & Mokdad AH. Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation. Diabetes Care200831587\u2013589. (https:\/\/doi.org\/10.2337\/dc07-1030)"},{"key":"bib9","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"E1579","article-title":"Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement","volume":"97","author":"Golden","year":"2012","unstructured":"Golden SHBrown ACauley JAChin MHGary-Webb TLKim CSosa JASumner AE & Anton B. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors--an Endocrine Society scientific statement. Journal of Clinical Endocrinology and Metabolism201297E1579\u2013E1639. (https:\/\/doi.org\/10.1210\/jc.2012-2043)"},{"key":"bib10","series-title":"Scientific Reports","first-page":"16168","article-title":"Validity of the gender dysphoria diagnosis and incidence trends in Sweden: a nationwide register study","volume":"11","author":"Indremo","year":"2021","unstructured":"Indremo MWhite RFrisell TCnattingius SSkalkidou AIsaksson J & Papadopoulos FC. Validity of the gender dysphoria diagnosis and incidence trends in Sweden: a nationwide register study. Scientific Reports20211116168. (https:\/\/doi.org\/10.1038\/s41598-021-95421-9)"},{"key":"bib11","series-title":"Journal of Sexual Medicine","first-page":"1381","article-title":"Evidence for a change in the sex ratio of children referred for gender dysphoria: data from the gender identity development service in London (2000\u20132017)","volume":"15","author":"de Graaf","year":"2018","unstructured":"de Graaf NMCarmichael PSteensma TD & Zucker KJ. Evidence for a change in the sex ratio of children referred for gender dysphoria: data from the gender identity development service in London (2000\u20132017). Journal of Sexual Medicine2018151381\u20131383. (https:\/\/doi.org\/10.1016\/j.jsxm.2018.08.002)"},{"key":"bib12","series-title":"European Journal of Endocrinology","first-page":"141","article-title":"An overview of clinical activities in Endo-ERN: the need for alignment of future network criteria","volume":"183","author":"de Vries","year":"2020","unstructured":"de Vries FBruin MCersosimo Avan Beuzekom CNAhmed SFPeeters RPBiermasz NRHiort O & Pereira AM. An overview of clinical activities in Endo-ERN: the need for alignment of future network criteria. European Journal of Endocrinology2020183141\u2013148. (https:\/\/doi.org\/10.1530\/EJE-20-0197)"},{"key":"bib13","series-title":"New England Journal of Medicine","first-page":"937","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","unstructured":"Melmed S. Pituitary-tumor endocrinopathies. New England Journal of Medicine2020382937\u2013950. (https:\/\/doi.org\/10.1056\/NEJMra1810772)"},{"key":"bib14","series-title":"JAMA","first-page":"516","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","unstructured":"Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. JAMA2017317516\u2013524. (https:\/\/doi.org\/10.1001\/jama.2016.19699)"},{"issue":"e220416","key":"bib15","series-title":"Endocrine Connections","article-title":"Outcome of COVID-19 infections in patients with adrenal insufficiency and excess","volume":"12","author":"Nowotny","year":"2023","unstructured":"Nowotny HFBryce JAli SRGiordano RBaronio FChifu ITschaidse LCools MVan den Akker ELTFalhammar H, et al.Outcome of COVID-19 infections in patients with adrenal insufficiency and excess. Endocrine Connections202312 e220416. (https:\/\/doi.org\/10.1530\/EC-22-0416)"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/12\/12\/EC-23-0434.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/12\/12\/EC-23-0434.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/12\/12\/EC-23-0434.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:47:00Z","timestamp":1784555220000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/1614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,30]]},"references-count":15,"journal-issue":{"issue":"12"},"URL":"https:\/\/doi.org\/10.1530\/ec-23-0434","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,30]]}}}